Compare LIND & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LIND | TLRY |
|---|---|---|
| Founded | 1979 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 899.2M | 919.2M |
| IPO Year | 2011 | 2018 |
| Metric | LIND | TLRY |
|---|---|---|
| Price | $20.10 | $8.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | $19.00 | ★ $103.33 |
| AVG Volume (30 Days) | 818.0K | ★ 2.8M |
| Earning Date | 06-01-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.72 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $19.55 | $7.39 |
| Revenue Next Year | $9.09 | $4.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.45 | $0.36 |
| 52 Week High | $21.23 | $15.70 |
| Indicator | LIND | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 61.86 | 51.34 |
| Support Level | $11.14 | $7.11 |
| Resistance Level | N/A | $8.31 |
| Average True Range (ATR) | 0.87 | 0.40 |
| MACD | -0.11 | 0.07 |
| Stochastic Oscillator | 59.34 | 73.54 |
Lindblad Expeditions Holdings Inc provides expedition cruising and adventure travel services. The company operates in two segments: Lindblad and Land Experiences, of which Lindblad generates the vast majority of its revenue. It offers itineraries that feature up-close encounters with wildlife, nature, history, and culture, as well as promote guest empowerment and interactivity. It operates expeditions on intimately-scaled ships and interaction between guests, crew, and the teams of scientists, naturalists, researchers, and photographers that participate in the expeditions. Lindblad operates a fleet of twelve owned expedition ships and five seasonal charter vessels under the Lindblad brand.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.